Document is current

Article History

Received: 17 September 2024

Accepted: 27 December 2024

First Online: 11 January 2025

Declarations

:

: The study was approved by the local ethics committee (Ethics committee, University Duisburg-Essen, Faculty of Medicine, protocol number 20-9226-BO) and performed in accordance with the Declaration of Helsinki. Written informed consent was requested.

: DK reports a research grant from Pfizer, funding by the German Research Foundation (DFG, KE2933/1–1), funding by the Universitätsmedizin Essen Clinician Scientist Academy (UMEA)/DFG (FU356/12–2), and speaker honoraria from Pfizer and Novartis outside of the submitted work. JH reports funding by the Universitätsmedizin Essen Clinician Scientist Academy (UMEA)/DFG (FU356/12–2) outside of the submitted work. TG reports funding by the Universitätsmedizin Essen Clinician Scientist Academy (UMEA)/DFG (FU356/12–2) outside of the submitted work. LU is a Speaker/Advisory Board Member for Bayer Healthcare and Siemens Healthcare and received research grants from Siemens Healthcare outside of the submitted work. CR is an editor in this journal and reports a research grant from Pfizer, consultancy for Adacap and Pfizer, and speaker honoraria from Adacap, Alnylam, BTG, Curium, GE Healthcare, Pfizer, and Siemens Healthineers outside of the submitted work. KH reports personal fees from Bayer, personal fees and other from Sofie Biosciences, personal fees from SIRTEX, non-financial support from ABX, personal fees from Adacap, personal fees from Curium, personal fees from Endocyte, grants and personal fees from BTG, personal fees from IPSEN, personal fees from Siemens Healthineers, personal fees from GE Healthcare, personal fees from Amgen, personal fees from Novartis, personal fees from ymabs, personal fees from Aktis Oncology, personal fees from Theragnostics, personal fees from Pharma15, personal fees from Debiopharm, personal fees from AstraZeneca, and personal fees from Janssen outside of the submitted work. WPF reports fees from SOFIE Bioscience (research funding), Janssen (consultant, speaker), Calyx (consultant, image review), Bayer (consultant, speaker, research funding), Novartis (speaker, consultant), Telix (speaker), GE Healthcare (speaker), Eczacıbaşı Monrol (speaker), Abx (speaker), Amgen (speaker), Urotrials (speaker) outside of the submitted work. MW reports fees from Boston Scientific, Terumo, Eli Lilly, and Advanced Accelerator Applications. RS has received research/travel funding from Else Kröner-Fresenius-Stiftung and Boehringer Ingelheim Fonds as well as speaker honoraria and travel support from Novartis and Boston Scientific outside of the submitted work.